Isomorphic Labs is a London-based drug developer that’s owned and operated by Alphabet Inc. The company was founded in 2021 as an offshoot from DeepMind, Google’s multidisciplinary AI research ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough ... DeepMind’s revolutionary AlphaFold AI system gave birth to Isomorphic Labs, which ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to address that disease,” Colin Murdoch, Isomorphic Labs president and Google ...

LONDON and BOSTON, June 17, 2025 /PRNewswire/ -- Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Researchers are urging developers to prioritize research into “chain-of-thought” processes, which provide a window into how ...